Community Practice

Albemarle to increase price of ibuprofen

NACDS applauds passage of House bill to delay tamper-resistant paper requirement

QIO sets up new MTM program for Maryland and District of Columbia

PhRMA testifies to Congress about the threat of drug counterfeiting

Wal-Mart expands its $4 generic plan to include more generics and adds birth control Rxs for $9.

Massachusetts hospitals paying for errors

FDA warns of adverse effects with buccal fentanyl use.

NACDS Foundation Chain Pharmacy Industry Profile highlights role of pharmacists

College of Pharmacy gets new home

NACDS debunks New York Times article, "The 'Poisonous Cocktail' of Multiple Drugs"

Inflated average wholesale prices issued by two publishers have resulted in high costs for consumers, who have filed class-action suits against them.

Oripavine is designated a Schedule II controlled substance by the Drug Enforcement Administration

National Quality Forum releases standards for substance abuse treatment

New on-line tool for calculating pain medication index

TWC Global issues recall of Axcil and Desirin

NCCN updates its dermatofibrosarcoma protuberans guidelines.

NCCN updates hepatobiliary cancer treatment guidelines.

ASHP launches on-line resource center

CMS outlines plans for contacting low-income subsidy beneficiaries for Medicare Part D program.

CVS/pharmacy to offer flu vaccinations in over 4,000 stores.

FDA warns about risk of Cryptosporidium illness from Baby's Bliss Gripe Water

Pharmacy owner pleads guilty to charges stemming from Affpower Internet pharmacy.

Hospitals swallowing cost of errors

Campath granted regular approval

New study results released for once-yearly Reclast (zoledronic acid) injection